← Back to Search

Sound Coding Strategies for Hearing Loss

N/A

Recruiting

Led By David M Landsberger, MD

Research Sponsored by NYU Langone Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be ages 18 or older and post-lingually implanted or have normal hearing.

Be ages 18-35 and pre-lingually implanted.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline visit (day 1) , visit week 10

Awards & highlights

Study Summary

This trial is studying how well cochlear implants work and if they improve sound perception. They will compare information from people with and without cochlear implants.

Who is the study for?

This trial is for children and adults with cochlear implants implanted before age 2, those who have some hearing left with aids, or normal hearing. It's open to ages 7-35 if pre-lingually implanted and 18+ for post-lingual implantation or normal hearing. Post-lingually implanted children cannot participate.Check my eligibility

What is being tested?

The study tests how different sound coding strategies in cochlear implants affect auditory performance. Participants will try electric-only spectral resolution methods and single-electrode pulse trains to see which improves sound perception.See study design

What are the potential side effects?

Since this trial involves non-invasive auditory testing rather than medication or surgery, there are minimal side effects expected. Some participants might experience fatigue or discomfort from wearing the testing equipment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 or older with either a cochlear implant received after learning to speak or normal hearing.

Select...

I am between 18 and 35 years old and received my implant before I could speak.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline visit (day 1) , visit week 10

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline visit (day 1) , visit week 10

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline visit (day 1) , visit week 10 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in loudness growth in Cochlear Implant participants

Change in spectral resolution in Cochlear implant participants

Change in temporal resolution in Cochlear implant participants

+1 more

Trial Design

6Treatment groups

Experimental Treatment

Active Control

Group I: Late Adult Cochlear Implant (LateAdultCI)Experimental Treatment3 Interventions

Post-lingually implanted adults, 18+ years

Group II: Early Child Cochlear Implant (EarlyChildCI)Experimental Treatment3 Interventions

Early implanted children, ages 7-17 years

Group III: Early Adult Cochlear Implant (EarlyAdultCI)Experimental Treatment2 Interventions

Early implanted adults, ages 18 to 35 years

Group IV: Cochlear Implant (CI)Experimental Treatment1 Intervention

CI children, ages 7-17 years, with aided residual hearing (bimodal/contralateral, electric+acoustic/ipsilateral)

Group V: Normal Hearing Adults (NHA)Active Control1 Intervention

18+ years, Control Group

Group VI: Normal Hearing Children (NHC)Active Control1 Intervention

Ages 7-17 years, Control Group

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor

1,369 Previous Clinical Trials

840,445 Total Patients Enrolled

16 Trials studying Hearing Loss

2,410 Patients Enrolled for Hearing Loss

David M Landsberger, MDPrincipal InvestigatorNYU Langone Health

Media Library

Cochlear Implant Clinical Trial Eligibility Overview. Trial Name: NCT05203302 — N/A

Hearing Loss Research Study Groups: Normal Hearing Adults (NHA), Late Adult Cochlear Implant (LateAdultCI), Early Child Cochlear Implant (EarlyChildCI), Early Adult Cochlear Implant (EarlyAdultCI), Cochlear Implant (CI), Normal Hearing Children (NHC)

Hearing Loss Clinical Trial 2023: Cochlear Implant Highlights & Side Effects. Trial Name: NCT05203302 — N/A

Cochlear Implant 2023 Treatment Timeline for Medical Study. Trial Name: NCT05203302 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this investigation offer opportunities for participants over the age of 55?

"To join this medical trial, patients must be within the age range of 6 to 80 years old. An additional 34 studies are available for individuals under 18 and 71 more trials exist for adults older than 65."

Answered by AI

Are applicants being received for this experiment at present?

"Clinicaltrials.gov attests to this medical trial's continued recruitment of patients, which commenced on July 12th 2018 and was most recently refreshed January 10th 2022."

Answered by AI

Are there any restrictions on who can partake in this scientific investigation?

"This clinical trial seeks 190 candidates aged between 6 to 80 years old who have hearing loss. Furthermore, applicants must satisfy additional criteria according to their age; adults above 18 should be post-lingually implanted or possess typical auditory acuity while those from 7 - 35 require pre-lingual implantation with a cochlear device before the age of 2 accompanied by residual hearing or normal capability."

Answered by AI

How many participants have been recruited for this trial?

"Affirmative. The clinicaltrials.gov database reveals that this study, which opened on July 12th 2018 is currently seeking applicants. 190 people are required to enroll at 1 medical centre for the trial's completion."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Novel Coding Strategies for Children With Cochlear Implants

2018. "Novel Coding Strategies for Children With Cochlear Implants". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05203302.

All > Hearing Loss